Pharmacodynamics and Pharmacokinetics of Citalopram and Escitalopram

PHASE1CompletedINTERVENTIONAL
Enrollment

927

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Depression
Interventions
DRUG

citalopram and escitalopram

"escitalopram tablets starting at 10 mg, increase to 20 mg at 4 weeks if QIDS-C16 \> 5, keep at same dose if QIDS-C16 \< 5.~citalopram tablet or solution starting at 2o mg, increase to 40 mg at 4 weeks if QIDS-C16 \> 5, keep at same dose if QIDS-C16 \< 5."

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Institute of General Medical Sciences (NIGMS)

NIH

collaborator

National Center for Research Resources (NCRR)

NIH

lead

Mayo Clinic

OTHER